Reapplix
Klaus Eldrup-Jørgensen has an extensive career within the life science industry, with experience from big pharma, diagnostics, and biotech companies. During his 16 years in this industry, he has gained experience in areas including research and development, clinical development, sales and marketing. Moreover, he has nine years of executive management experience from Novo Nordisk, DAKO, and Nordic Bioscience. He is also the founder of several start-up companies and he holds several board positions in high-tech companies.
Today Klaus is Co-founder, majority shareholder and CEO in TrackMan A/S, a sports data and technology company founded in 2003.
Klaus Eldrup-Jørgensen has an MD from the University of Copenhagen and a B.Sc. from Copenhagen Business School.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Reapplix
1 followers
Reapplix identifies blood-derived proteins that improve wound healing, isolates them, and reapplies them to patients with chronic wounds.